This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 1994-1995.
Company Filing History:
Years Active: 1994-1995
Title: Alan Shuttleworth: Innovator in Biochemical Compounds
Introduction
Alan Shuttleworth is a notable inventor based in Greenford, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have potential therapeutic applications. With a total of 2 patents to his name, Shuttleworth's work is recognized for its innovative approach to addressing health-related challenges.
Latest Patents
Shuttleworth's latest patents include the development of cyclic ketal derivatives. These compounds are described by a specific formula where various groups are represented, including hydrogen atoms and hydroxyl groups. The compounds are designed to inhibit the enzyme squalene synthase, which plays a crucial role in cholesterol synthesis. Additionally, these compounds may serve as intermediates for preparing other compounds that also inhibit this enzyme. The invention has potential applications in lowering blood plasma cholesterol levels and combating fungal infections in animals.
Career Highlights
Throughout his career, Alan Shuttleworth has been associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work has contributed to advancements in drug development and has been instrumental in creating solutions for various health issues.
Collaborations
Shuttleworth has collaborated with notable colleagues, including Robert M Tait and Michael V Hayes. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Alan Shuttleworth's contributions to the field of biochemistry through his innovative patents highlight his role as a significant inventor. His work continues to impact the pharmaceutical industry positively, paving the way for future advancements in health-related solutions.